Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home
Share
Compartir

Prevention

Vaccine

The best way to prevent pneumococcal disease is to vaccinate your patients.

The pneumococcal conjugate vaccine (PCV13 or Prevnar 13®) provides protection against the 13 serotypes responsible for most severe illness in children. The vaccine can also help prevent some ear infections. PCV13 is administered as a four-dose series at 2, 4, 6, and 12 through 15 months of life. It has been shown to be very effective in preventing infection resulting from the serotypes contained in the vaccine. PCV13 should also be administered to some adults with immunocompromising conditions.

The pneumococcal polysaccharide vaccine (PPSV23 or Pneumovax 23®) is a 23-valent polysaccharide vaccine that is currently recommended for use in all adults who are 65 years and older and for persons who are 2 years and older and at high risk for disease. It is also recommended for use in adults 19 through 64 years of age who smoke cigarettes or who have asthma.

It’s also important to administer an influenza vaccination every year because having the flu increases your patient’s chances of getting pneumococcal disease.

For more information on who should get a pneumococcal vaccine, see the ACIP recommendations.

Top of Page

Chemoprophylaxis

For children with functional or anatomic asplenia, especially those with sickle-cell disease, daily antimicrobial prophylaxis with oral penicillin V or G is typically recommended. In general, antimicrobial prophylaxis (in addition to immunization) should be considered for all children with asplenia younger than 5 years of age and for at least 1 year after splenectomy.

Because secondary cases of invasive pneumococcal infection are uncommon, chemoprophylaxis is not indicated for contacts of patients with such infection.

 

References

American Academy of Pediatrics. Children with asplenia or functional asplenia. In: Pickering LK, Baker CI, Kimberlin DW, Long SS, eds. Red Book: 2009 Report of the Committee on Infectious Diseases, 28th ed. Elk Grove Village, IL; 2009:72.

 

Related Links

Top of Page

 

Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more

External Web Site Policy This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
    Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #